Stockscreener 앱 받기
0.725
3.20%
-0.024
시간 외 거래:
.72
-0.005
-0.69%
전일 마감가:
$0.749
열려 있는:
$0.75
하루 거래량:
518.15K
Relative Volume:
1.36
시가총액:
$69.77M
수익:
$169.43M
순이익/손실:
$-186.01M
주가수익비율:
-0.3589
EPS:
-2.02
순현금흐름:
$70.07M
1주 성능:
-12.10%
1개월 성능:
-12.60%
6개월 성능:
+5.67%
1년 성능:
-23.68%
1일 변동 폭
$0.71
$0.7686
1주일 범위
$0.71
$0.8343
52주 변동 폭
$0.5137
$1.0791
애서티오 홀딩스 Stock (ASRT) Company Profile
명칭
Assertio Holdings Inc
전화
(224) 419-7106
주소
100 S. SAUNDERS ROAD, LAKE FOREST, IL
ASRT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
0.725 | 72.09M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
애서티오 홀딩스 Stock (ASRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-26 | 개시 | Maxim Group | Buy |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2022-11-07 | 개시 | Lake Street | Buy |
| 2018-11-30 | 다운그레이드 | Mizuho | Buy → Neutral |
애서티오 홀딩스 주식(ASRT)의 최신 뉴스
Can Assertio Holdings Inc. stock beat market expectations this quarterJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Will Assertio Holdings Inc. stock attract ESG investorsNew Guidance & Real-Time Market Trend Scan - newser.com
Applying Elliott Wave Theory to Assertio Holdings Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Is Assertio Holdings Inc. stock oversold or undervaluedPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
The growth track for Assertio Holdings Inc (ASRT) has changed recently - Setenews
Automated trading signals detected on Assertio Holdings Inc.2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Will Assertio Holdings Inc. stock benefit from AI adoptionMarket Activity Recap & Safe Entry Trade Reports - newser.com
How Assertio Holdings Inc. stock compares to market leadersJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
Using AI based signals to follow Assertio Holdings Inc.Quarterly Profit Review & Target Return Focused Stock Picks - newser.com
How to manage a losing position in Assertio Holdings Inc.Weekly Market Report & Weekly Consistent Profit Watchlists - newser.com
Visualizing Assertio Holdings Inc. stock with heatmapsFed Meeting & Daily Risk Controlled Trade Plans - newser.com
What does recent volatility data suggest for Assertio Holdings Inc.2025 Investor Takeaways & Community Consensus Picks - newser.com
Intraday pattern recognizer results for Assertio Holdings Inc.2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Will Assertio Holdings Inc. stock sustain high P E ratiosJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Why Assertio Holdings Inc. stock is seen as undervaluedRisk Management & Weekly Stock Performance Updates - newser.com
Assertio Holdings, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Yahoo Finance
Assertio Holdings director Stark sells $6806 in shares By Investing.com - Investing.com Nigeria
Assertio Holdings director Stark sells $6806 in shares - Investing.com
An analyst sees good growth prospects for Assertio Holdings Inc (ASRT) - Setenews
Assertio Therapeutics Promotes Paul Schwichtenberg to President - MSN
Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2025 Earnings Call Transcript - Insider Monkey
Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... By GuruFocus - Investing.com Canada
Key metrics from Assertio Holdings Inc.’s quarterly dataJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Earnings call transcript: assertio therapeutics beats Q3 2025 forecasts By Investing.com - Investing.com Nigeria
Assertio: Q3 Earnings Snapshot - CTPost
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com
Assertio narrows 2025 guidance to $110M–$112M as Rolvedon pull-forward shapes cash flow outlook - MSN
Earnings call transcript: assertio therapeutics beats Q3 2025 forecasts - Investing.com India
애서티오 홀딩스 (ASRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.17%
0.67%
자본화:
|
볼륨(24시간):